These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8586722)

  • 21. Analysis of clonal relationships among isolates of Shigella sonnei by different molecular typing methods.
    Liu PY; Lau YJ; Hu BS; Shyr JM; Shi ZY; Tsai WS; Lin YH; Tseng CY
    J Clin Microbiol; 1995 Jul; 33(7):1779-83. PubMed ID: 7545179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping.
    Ryley HC; Millar-Jones L; Paull A; Weeks J
    J Med Microbiol; 1995 Dec; 43(6):436-41. PubMed ID: 7473677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA fingerprinting of Pseudomonas aeruginosa serotype O11 by enterobacterial repetitive intergenic consensus-polymerase chain reaction and pulsed-field gel electrophoresis.
    Lau YJ; Liu PY; Hu BS; Shyr JM; Shi ZY; Tsai WS; Lin YH; Tseng CY
    J Hosp Infect; 1995 Sep; 31(1):61-6. PubMed ID: 7499822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia.
    Dasen SE; LiPuma JJ; Kostman JR; Stull TL
    J Clin Microbiol; 1994 Oct; 32(10):2422-4. PubMed ID: 7529239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological typing of isolates from an outbreak of infection with multidrug-resistant Enterobacter cloacae by repetitive extragenic palindromic unit b1-primed PCR and pulsed-field gel electrophoresis.
    Shi ZY; Liu PY; Lau YJ; Lin YH; Hu BS
    J Clin Microbiol; 1996 Nov; 34(11):2784-90. PubMed ID: 8897183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.
    Coenye T; Spilker T; Martin A; LiPuma JJ
    J Clin Microbiol; 2002 Sep; 40(9):3300-7. PubMed ID: 12202570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
    Pitt TL; Kaufmann ME; Patel PS; Benge LC; Gaskin S; Livermore DM
    J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients.
    Tyler SD; Rozee KR; Johnson WM
    J Clin Microbiol; 1996 Jul; 34(7):1610-6. PubMed ID: 8784555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center.
    Richau JA; Leitão JH; Correia M; Lito L; Salgado MJ; Barreto C; Cescutti P; Sá-Correia I
    J Clin Microbiol; 2000 Apr; 38(4):1651-5. PubMed ID: 10747161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
    Campana S; Taccetti G; Ravenni N; Favari F; Cariani L; Sciacca A; Savoia D; Collura A; Fiscarelli E; De Intinis G; Busetti M; Cipolloni A; d'Aprile A; Provenzano E; Collebrusco I; Frontini P; Stassi G; Trancassini M; Tovagliari D; Lavitola A; Doherty CJ; Coenye T; Govan JR; Vandamme P
    J Clin Microbiol; 2005 Oct; 43(10):5136-42. PubMed ID: 16207975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outbreak of Burkholderia cepacia bacteraemia in a tertiary care centre due to contaminated ultrasound probe gel.
    Abdelfattah R; Al-Jumaah S; Al-Qahtani A; Al-Thawadi S; Barron I; Al-Mofada S
    J Hosp Infect; 2018 Mar; 98(3):289-294. PubMed ID: 28923373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular typing by pulsed field gel electrophoresis of Pseudomonas (Burkholderia) cepacia isolated from a nosocomial infection].
    Rodriguez P; Fourmaux S; de Barbeyrac B; Rogues AM; Parneix P; Leger A; Bebear C
    Pathol Biol (Paris); 1995 Apr; 43(4):352-7. PubMed ID: 7567128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland.
    Crowley D; Daly M; Lucey B; Shine P; Collins JJ; Cryan B; Moore JE; Murphy P; Buckley G; Fanning S
    J Appl Microbiol; 2002; 92(5):992-1004. PubMed ID: 11972706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of an automated repetitive-sequence-based PCR instrument versus pulsed-field gel electrophoresis in the setting of a Serratia marcescens nosocomial infection outbreak.
    Ligozzi M; Fontana R; Aldegheri M; Scalet G; Lo Cascio G
    J Clin Microbiol; 2010 May; 48(5):1690-5. PubMed ID: 20237095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing uncommon Burkholderia cepacia complex isolates from an outbreak in a haemodialysis unit.
    Souza AV; Moreira CR; Pasternak J; Hirata ML; Saltini DA; Caetano VC; Ciosak S; Azevedo FM; Severino P; Vandamme P; Magalhães VD
    J Med Microbiol; 2004 Oct; 53(Pt 10):999-1005. PubMed ID: 15358822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of use of whole-cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for typing strains belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex and application of the method to the investigation of a hospital outbreak.
    Snelling AM; Gerner-Smidt P; Hawkey PM; Heritage J; Parnell P; Porter C; Bodenham AR; Inglis T
    J Clin Microbiol; 1996 May; 34(5):1193-202. PubMed ID: 8727902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit.
    Liao CH; Chang HT; Lai CC; Huang YT; Hsu MS; Liu CY; Yang CJ; Hsueh PR
    Diagn Microbiol Infect Dis; 2011 Jun; 70(2):260-6. PubMed ID: 21392926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis.
    Coenye T; LiPuma JJ
    J Infect Dis; 2002 May; 185(10):1454-62. PubMed ID: 11992281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of PCR-based approaches to molecular epidemiologic analysis of Clostridium difficile.
    Collier MC; Stock F; DeGirolami PC; Samore MH; Cartwright CP
    J Clin Microbiol; 1996 May; 34(5):1153-7. PubMed ID: 8727893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.